Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report

Clear cell tumours of the ovary are relatively uncommon. Most of them are clear cell carcinomas. Benign and borderline clear cell tumours are extremely rare and almost always fibromatous. We report a case of a 34-year-old woman. Ultrasound and computed tomography showed a right ovarian mass 8 cm in diameter. The patient underwent right salpingo-oophorectomy. Microscopic examination revealed glands and cysts different in size and shape within an abundant stromal component without evidence of stromal invasion. Many cysts and glands were lined by a single layer of flattened, cuboidal or hobnail cells with mild to moderate cytologic atypia and prominent nucleoli. Psammomatous calcifications were occasionally indentified. Features of endometriosis were also present adjacent to the tumour. Lesional cells were positive for Ker 7 and CA 125. Staining for p53 was focally positive. Based on the above characteristic morphologic and immunohistochemical findings a diagnosis of borderline clear cell adenofibroma was made. The patient was free of recurrence four years after surgery.

Clear cell tumour; Ovary; Adenofibroma; Endometriosis

[1] Tohya T., Mizutani H., Katabuchi H., Miyazaki K., Okamura H.: “Mucinous adenofibroma of the ovary: case report of the endocrinologic findings”. Gynecol. Oncol., 1994, 54, 218.

[2] Bell D., Scully R.: “Benign and borderline clear cell adenofibrous of the ovary”. Cancer, 1985, 56, 2922.

[3] Zhang L., Ray M., Moore G.: “An 82 year old woman with a 25 cm abdominal mass”. Arch. Pathol. Lab. Med., 2004, 129, 162.

[4] Suzuki A., Shiozawa T., Mori A., Kimura K., Konishi I.: “Cystic clear cell tumour of borderline malignancy of the ovary lacking fibromatous components: Report of two cases and a possible new histological subtype”. Gynecol. Oncol., 2006, 101, 540.

[5] Prat J: “Ovarian tumors of borderline malignancy (tumors of low malignant potential: a critical appraisal”. Adv. Anat. Pathol., 1999, 5, 247.

[6] Pasaoglu O., Ciftci E., Tel. N., Ozalp. S., Acikalin M.F.: “Benign clear cell Adenofibroma of the ovary. A case report with literature review”. Gynecol. Obstet. Invest., 2007, 64, 36.

[7] Roth L., Langley F., Fox. H., Wheeler J., Czernobilsky B.: “Ovarian clear cell adenofibromatous tumours benign, of low malignant potential and associated with invasive clear cell adenocarcinoma”. Cancer, 1984, 53, 1156.

[8] Katsube Y., Fujiwara H., Tanioka Y., Imajo M., Fujiwara A.: “Ovarian clear cell adenofibroma of borderline malignancy. A case report”. Hiroshima J. Med. Sci., 1989, 38, 87.

[9] Momotani K., Tanaka T., Iwai E., Kanda T., Munakata S., Ohmichi M.: “Ovarian clear cell adenofibromatous tumour of borderline malignancy associated with high levels of carbohydrate antigen 19-9”. J. Obstet. Gynaecol. Res., 2011, 37, 472.

[10] Modesitt S., Tortolero-Luna G., Robinson J.B., Gershenson D.M., Wolf J.K.: “Ovarian and extraovarian endometriosis-associated cancer”. Obstet. Gynecol., 2002, 100, 788.

[11] Ogawa S., Kaku T., Amada S., Kobayashi H., Hirakawa T., Ariyoshi K.: “Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study”. Gynecol. Oncol., 2000, 77, 298.

[12] Zhao C., Wu L.S., Barner R.: “Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development”. J. Cancer, 2011, 2, 94.

[13] Kato N., Sason S., Motoyama T.: “Expression of hepatocyte nuclear factor-1 beta (HNF-1 beta) in clear cell tumors and endometriosis of the ovary”. Mod. Pathol., 2006, 19, 83.

[14] Tsuchiya A., Sakamoto M., Yasuda J., Chuma M., Ohta T., Ohki M. et al.: “Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor 1 beta as molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma”. Am. J. Pathol., 2003, 163, 2503.